Pheon Therapeutics
PrivateLast Round
Series B
May 21, 2024
Total Funding Raised
$188M
Company Overview
Pheon Therapeutics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series B round in May 2024.
Pheon Therapeutics is a biotechnology company developing next-generation antibody-drug conjugates (ADCs) for a wide range of hard-to-treat cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pheon Therapeutics Comparables
Compare Pheon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adcendo | 86% | |
| TORL BioTherapeutics | 84% | |
| Novartis | 83% |
For institutional investors. Book with your work email.
Pheon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 21, 2024 | ||||
| Series A | Mar 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pheon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abio-X | Series B |
| Forbion Capital Partners | Series B, Series A |
| TCG Crossover | Series B |
| Research Corporation Technologies | Series B, Series A |
| Forbion | Series B, Series A |
| Perceptive Advisors | Series B |
| RCT | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
Developing new cdcp1-targeting antibody-drug conjugates (ADCs).
- May 21, 2024
$120M round led by TCG Crossover
For institutional investors. Book with your work email.
Pheon Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pheon Therapeutics's valuation, stock price, and market status.
Is Pheon Therapeutics a public or private company?
Pheon Therapeutics is a private company.
What is the current stock price of Pheon Therapeutics?
Pheon Therapeutics is a private company, so its shares have no public market price. Caplight tracks Pheon Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pheon Therapeutics worth (valuation)?
Valuation information for Pheon Therapeutics is not publicly available.
Can I buy Pheon Therapeutics stock?
Pheon Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pheon Therapeutics's last funding round?
Pheon Therapeutics's most recent funding round was Series B on May 21, 2024.
Who are the main investors in Pheon Therapeutics?
Key investors in Pheon Therapeutics include Forbion Capital Partners, TCG Crossover, Forbion, Atlas Venture, Brandon Capital.
Will Pheon Therapeutics IPO soon?
No public IPO plans have been announced for Pheon Therapeutics.
How can I track Pheon Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Pheon Therapeutics's shares on secondary markets.